查看购物车
  • Traditional Chinese
  • English
欧洲肠内营养市场规模及预测 2021-2031、区域份额、趋势及成长机会分析报告范围：依产品类型（鼻胃管、鼻肠管、吸饮管及其他）及国家/地区
市场调查报告书
商品编码
1646530

欧洲肠内营养市场规模及预测 2021-2031、区域份额、趋势及成长机会分析报告范围：依产品类型（鼻胃管、鼻肠管、吸饮管及其他）及国家/地区

Europe Enteral Nutrition Market Size and Forecast 2021-2031, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Nasogastric, Nasoenteral, Sipping, and Others) and Country
出版日期: | 出版商: The Insight Partners | 英文 124 Pages | 订单完成后即时交付

价格

欧洲肠内营养市场规模预计将从 2023 年的 33.2 亿美元增至 2031 年的 57.9 亿美元。

标准化配方和植物营养产品

消费者对帮助主动管理健康的产品的需求激增，尤其是那些专注于能量水平、免疫力和疾病治疗方面的特定需求的产品。肠内产品的功能和特定配方不会干扰患者现有的治疗。肠内营养的常量营养素和微量营养素配方及其应用根据所考虑的疾病而有所不同。等热量肠内营养配方（1 kcal/ml）通常用于实现估计或测量的热量目标，而高能量配方（>1 kcal/ml）则用于增加胃肠功能障碍患者的热量输送。

标准化的肠内营养产品含有固定的成分，旨在满足患者的平均营养需求，同时考虑到不同年龄层患者的需求不同。例如，Peptamen Formula（雀巢）是唯一含有酵素水解 100% 乳清蛋白的胜肽基配方，有助于克服管饲不耐症。此类管饲配方是专门的肠内营养产品，旨在支持患有胃肠道疾病的患者的吸收并克服耐受机制。

越来越多的人开始选择植物性食物，引发了全球对植物性营养产品的需求。人们对大量使用的人工/合成成分的耐受性越来越差，因为这可能会引发不良反应。 2020 年 Innova 消费者调查显示，健康、饮食多样性、永续性和口味是人们考虑植物性替代品的主要原因。雅培表示，消费者和依赖管饲的患者也非常关注这些参数。欧洲肠内营养市场的公司正在利用各个人口群体对健康食品日益增长的偏好来获利。因此，Kate Farms、Functional Formularies 和 Real Food Blends 等公司开发了更多天然、植物性的肠内产品。 2021 年 8 月，Kate Farms 推出了首个封闭式餵食系统，以 1 公升容量的即挂袋形式提供植物配方奶粉。 Kate Farms Standard 1.4 纯天然配方和 Peptide 1.5 纯天然配方是植物性、有机、热量密集产品，可作为管饲中补充营养的唯一来源。 2021 年 9 月，雅培针对儿童和成人推出了一系列植物性蛋白质和有机食品成分。

因此，功能性、以患者为中心的配方和植物性营养产品是欧洲肠内营养市场的主要新兴趋势。

法国肠道营养市场分析

根据 2023 年 3 月《世界报》发表的一篇文章，法国 60 岁及以上人口的比例预计将从 2023 年的约 20% 飙升至 2050 年的约 30%。 2030-2050 年期间将达到近90%。老年人常患有糖尿病、心血管疾病和神经系统疾病（例如中风、帕金森氏症和阿兹海默症）等慢性疾病。这些情况会损害正常进食能力，导致营养不良并需要肠内餵食。根据全球癌症观察站统计，2022年法国通报癌症新发病例483,568例，患病病例数（5年）为1,494,814例。癌症与肠内营养有密切关係。许多癌症患者因疾病本身或接受的治疗而营养不良，这会损害他们进食和吸收必需营养素的能力。

Fresenius Kabir France 提供多样化的即用型肠内营养产品，如管饲、口服营养补充剂 (ONS) 和粉末产品。针对吞嚥困难患者，该公司提供不同浓稠度的质地改良产品，以满足不同患者的个人需求。

欧洲肠内营养市场报告細項分析

有助于得出欧洲肠内营养市场分析的关键部分是类型、材料和最终用户。

根据产品类型，欧洲肠内营养市场分为鼻胃管、鼻肠管、吸入管和其他管。 2023 年，鼻胃管领域占据了市场的最大份额。

欧洲肠内营养市场的一些知名企业包括雀巢、达能公司、雅培实验室、菲仕兰坎皮纳、费森尤斯集团、贝朗公司、Dr. Schar AG、Arla Food、利洁时、百利戈公司、其中包括恆天然合作集团有限公司、Kate Farms 和 Nutritional Medicinals, LLC。

公司正在推出新的创新产品和服务，以维持其在欧洲肠内营养市场的地位。 2021年11月，雅培推出 Similac 360 Total Care，支持免疫系统、消化系统健康和大脑发展。 Similac 360 Total Care 是美国第一款也是唯一一款混合了五种不同 HMO 的婴儿配方奶粉，此前这些 HMO 仅在母乳中同时存在。此配方奶粉旨在提供营养以支持婴儿的整个健康和发育，包括正在发育的免疫系统、消化系统和大脑。

目录

第 1 章：简介

第 2 章：执行摘要

  • 关键见解

第三章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 发育基数：
    • 数据三角测量：
    • 国家级资料：

第 4 章：欧洲肠内营养市场格局

  • 概述
  • PEST分析
  • 定价分析
  • 饮水配方定价分析
  • 五大市场主要参与者名单
    • 德国、法国、英国的主要市场参与者

第 5 章：欧洲肠内营养市场 - 主要市场动态

  • 欧洲肠内营养市场 - 主要市场动态
  • 市场驱动因素
    • 胃肠道疾病发生率不断上升
    • 营养不良和早产病例增加
  • 市场限制
    • 与餵食系统相关的机械、胃肠道和代谢併发症
  • 市场机会
    • 主要市场参与者的策略性倡议
  • 未来趋势
    • 标准化配方和植物营养产品
  • 驱动因素和限制因素的影响：

第 6 章：欧洲肠内营养市场分析

  • 2021 至 2031 年欧洲肠内营养市场收入
  • 欧洲肠内营养市场预测与分析
  • 肠内和肠外市场价值 (%)

第 7 章：欧洲肠内营养市场分析 - 依产品类型

  • 鼻胃管
  • 经鼻肠
  • 啜饮
  • 其他的

第 8 章：欧洲肠内营养市场-国家分析

  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 捷克共和国
    • 欧洲其他地区

第九章：产业格局

  • 概述
  • 欧洲肠内营养市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第十章：公司简介

  • Nestle SA
  • Danone SA
  • Abbott Laboratories
  • Royal FrieslandCampina NV
  • Fresenius SE & Co KGaA
  • B Braun SE
  • Reckitt Benckiser Group Plc
  • Kate Farms Inc
  • Dr Schar AG
  • Fonterra Co-Operative Group Ltd
  • Arla Foods amba
  • Perrigo Co Plc
  • Charing Cross Scientific AS
  • Bexen Medical

第 11 章：附录

Product Code: TIPRE00039375

The Europe enteral nutrition market size is projected to reach US$ 5.79 billion by 2031 from US$ 3.32 billion in 2023. The market is expected to register a CAGR of 7.2% during 2023-2031.

Standardized Formulations and Plant-Based Nutrition Products

There is a surge in the demand for products that help consumers proactively manage their health, especially those focused on specific needs in terms of energy levels, immunity, and disease treatment. Functionality and specific formulations of enteral products do not interfere with the existing treatments of patients. The macro-nutrient and micronutrient formulations of enteral nutrition and their applications vary based on the disease under consideration. Isocaloric enteral nutrition formulation (1 kcal/ml) is generally prescribed to achieve estimated or measured caloric goals, while energy-dense formulae (>1 kcal/ml) are prescribed to increase calorie delivery in patients with gastrointestinal dysfunction.

Standardized enteral nutrition products contain fixed constituents and are designed to meet the average nutritional requirements of patients, considering that the requirements differ in different age groups. For example, Peptamen Formula (Nestle) is the only peptide-based formula with enzymatically hydrolyzed 100% whey protein that helps overcome tube-feeding intolerance. Such tube-feeding formulas are specialized enteral nutrition products designed to support absorption and overcome tolerance mechanisms in individuals with gastrointestinal disorders.

A surge in the number of people turning to plant-based food triggers the demand for plant-based nutrition products worldwide. People are becoming increasingly intolerant of artificial/synthetically sourced ingredients used in higher numbers, which may lead to adverse reactions. The Innova Consumer Survey 2020 showed that health, diet variety, sustainability, and taste are among the top reasons why people consider plant-based alternatives. Abbott states that consumers and patients relying on tube feeding also pay much attention to these parameters. Companies in the Europe enteral nutrition market are capitalizing on the growing preference for healthy foods in various demographic groups. As a result, companies such as Kate Farms, Functional Formularies, and Real Food Blends have developed more natural, plant-based enteral products. In August 2021, Kate Farms launched the first closed feeding system delivering plant-based formulas in ready-to-hang bags of 1 L capacity. Kate Farms Standard 1.4 plain and Peptide 1.5 plain formulations are plant-based, organic, calorically dense products that are used as a sole source of supplemental nutrition in tube feeding. In September 2021, Abbott introduced a portfolio of plant-based proteins and organic food ingredients for children and adults.

Therefore, functional, patient-centric formulations and plant-based nutrition products are the prime emerging trends in the Europe enteral nutrition market.

France Enteral Nutrition Market Analysis

According to a Le Monde article published in March 2023, the population share of people aged 60 or more in France is expected to surge from ~20% in 2023 to ~30% by 2050. The number of people aged 85 and above would grow by nearly 90% during 2030-2050. Older adults often experience chronic conditions such as diabetes, cardiovascular diseases, and neurological disorders (e.g., stroke, Parkinson's disease, and Alzheimer's). These conditions can impair the ability to eat normally, leading to malnutrition and requiring enteral feeding. According to the Global Cancer Observatory, France reported 483,568 new cancer cases in 2022, and the number of prevalent cases (5-year) was 1,494,814. Cancer and enteral nutrition are closely connected. Many cancer patients suffer from malnutrition due to the disease itself or the treatments they receive, which can impair their ability to eat and absorb essential nutrients.

Fresenius Kabir France offers a diverse portfolio of ready-to-use enteral nutrition products such as tube feeds, oral nutritional supplements (ONS), and powder products. For patients with dysphagia, the company offers texture-modified products in different consistencies to meet the individual needs of different patients.

Europe Enteral Nutrition Market Report Segmentation Analysis

Key segments that contributed to the derivation of the Europe enteral nutrition market analysis are type, material, and end user.

Based on product type, the Europe enteral nutrition market is segmented into Nasogastric, Nasoenteral, Sipping and Others. The nasogastric segment held the largest share of the market in 2023.

A few prominent players operating in the Europe enteral nutrition market are Nestle, Danone S.A., Abbott Laboratories, Friesland Campina, Fresenius SE and Co. KGaA, B. Braun SE, Dr. Schar AG, Arla Food, Reckitt Benckiser, Perrigo Company PLC, Fonterra Co-operative Group Limited, Kate Farms, and Nutritional Medicinals, LLC among others.

Companies are launching new and innovative products and services to sustain their position in the Europe enteral nutrition market size. In November 2021, Abbott Launched Similac 360 Total Care to Support the Immune System, Digestive Health, and Brain Development. Similac 360 Total Care is the first and only infant formula in the U.S. with a blend of five different HMOs, previously only found together in breast milk. This formula is designed to provide nutrition to support the whole baby's health and development, including the developing immune system, digestive system, and brain.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Europe Enteral Nutrition Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Pricing Analysis
  • 4.4 Pricing Analysis for Sipping Formula
  • 4.5 List of Key Market Players in Top 5 Market
    • 4.5.1 Major Market players in Germany, France, United Kingdom

5. Europe Enteral Nutrition Market - Key Market Dynamics

  • 5.1 Europe Enteral Nutrition Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Prevalence of Gastrointestinal Diseases
    • 5.2.2 Rising Cases of Malnutrition and Premature Births
  • 5.3 Market Restraints
    • 5.3.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Feeding Systems
  • 5.4 Market Opportunities
    • 5.4.1 Strategic Initiatives by Key Market Players
  • 5.5 Future Trends
    • 5.5.1 Standardized Formulations and Plant-Based Nutrition Products
  • 5.6 Impact of Drivers and Restraints:

6. Europe Enteral Nutrition Market Analysis

  • 6.1 Europe Enteral Nutrition Market Revenue (US$ Million), 2021-2031
  • 6.2 Europe Enteral Nutrition Market Forecast and Analysis
  • 6.3 Enteral and Parenteral Market Value (%)

7. Europe Enteral Nutrition Market Analysis - by Product Type

  • 7.1 Nasogastric
    • 7.1.1 Overview
    • 7.1.2 Nasogastric: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
    • 7.1.3 Standard
      • 7.1.3.1 Overview
      • 7.1.3.2 Standard: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
    • 7.1.4 Disease Specific
      • 7.1.4.1 Overview
      • 7.1.4.2 Disease Specific: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Nasoenteral
    • 7.2.1 Overview
    • 7.2.2 Nasoenteral: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Sipping
    • 7.3.1 Overview
    • 7.3.2 Sipping: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Enteral Nutrition Market - Country Analysis

  • 8.1 Europe
    • 8.1.1 Europe Enteral Nutrition Market Breakdown by Countries
    • 8.1.2 Europe Enteral Nutrition Market Revenue and Forecast and Analysis - by Country
      • 8.1.2.1 Europe Enteral Nutrition Market Revenue and Forecast and Analysis - by Country
      • 8.1.2.2 Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.2.2.1 Germany: Europe Enteral Nutrition Market Breakdown by Product Type
        • 8.1.2.2.2 Germany: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
        • 8.1.2.2.3 Germany: Europe Enteral Nutrition Market Breakdown by Standard By Calories
        • 8.1.2.2.4 Germany: Europe Enteral Nutrition Market Breakdown by Isocaloric
        • 8.1.2.2.5 Germany: Europe Enteral Nutrition Market Breakdown by Hypercaloric
        • 8.1.2.2.6 Germany: Europe Enteral Nutrition Market Breakdown by Standard By Type
        • 8.1.2.2.7 Germany: Europe Enteral Nutrition Market Breakdown by Standard By End User
      • 8.1.2.3 United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.2.3.1 United Kingdom: Europe Enteral Nutrition Market Breakdown by Product Type
        • 8.1.2.3.2 United Kingdom: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
        • 8.1.2.3.3 United Kingdom: Europe Enteral Nutrition Market Breakdown by Standard By Calories
        • 8.1.2.3.4 United Kingdom: Europe Enteral Nutrition Market Breakdown by Isocaloric
        • 8.1.2.3.5 United Kingdom: Europe Enteral Nutrition Market Breakdown by Hypercaloric
        • 8.1.2.3.6 United Kingdom: Europe Enteral Nutrition Market Breakdown by Standard By Type
        • 8.1.2.3.7 United Kingdom: Europe Enteral Nutrition Market Breakdown by Standard By End User
      • 8.1.2.4 France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.2.4.1 France: Europe Enteral Nutrition Market Breakdown by Product Type
        • 8.1.2.4.2 France: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
        • 8.1.2.4.3 France: Europe Enteral Nutrition Market Breakdown by Standard By Calories
        • 8.1.2.4.4 France: Europe Enteral Nutrition Market Breakdown by Isocaloric
        • 8.1.2.4.5 France: Europe Enteral Nutrition Market Breakdown by Hypercaloric
        • 8.1.2.4.6 France: Europe Enteral Nutrition Market Breakdown by Standard By Type
        • 8.1.2.4.7 France: Europe Enteral Nutrition Market Breakdown by Standard By End User
      • 8.1.2.5 Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.2.5.1 Italy: Europe Enteral Nutrition Market Breakdown by Product Type
        • 8.1.2.5.2 Italy: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
        • 8.1.2.5.3 Italy: Europe Enteral Nutrition Market Breakdown by Standard By Calories
        • 8.1.2.5.4 Italy: Europe Enteral Nutrition Market Breakdown by Isocaloric
        • 8.1.2.5.5 Italy: Europe Enteral Nutrition Market Breakdown by Hypercaloric
        • 8.1.2.5.6 Italy: Europe Enteral Nutrition Market Breakdown by Standard By Type
        • 8.1.2.5.7 Italy: Europe Enteral Nutrition Market Breakdown by Standard By End User
      • 8.1.2.6 Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.2.6.1 Spain: Europe Enteral Nutrition Market Breakdown by Product Type
        • 8.1.2.6.2 Spain: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
        • 8.1.2.6.3 Spain: Europe Enteral Nutrition Market Breakdown by Standard By Calories
        • 8.1.2.6.4 Spain: Europe Enteral Nutrition Market Breakdown by Isocaloric
        • 8.1.2.6.5 Spain: Europe Enteral Nutrition Market Breakdown by Hypercaloric
        • 8.1.2.6.6 Spain: Europe Enteral Nutrition Market Breakdown by Standard By Type
        • 8.1.2.6.7 Spain: Europe Enteral Nutrition Market Breakdown by Standard By End User
      • 8.1.2.7 Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.2.7.1 Czech Republic: Europe Enteral Nutrition Market Breakdown by Product Type
        • 8.1.2.7.2 Czech Republic: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
        • 8.1.2.7.3 Czech Republic: Europe Enteral Nutrition Market Breakdown by Standard By Calories
        • 8.1.2.7.4 Czech Republic: Europe Enteral Nutrition Market Breakdown by Isocaloric
        • 8.1.2.7.5 Czech Republic: Europe Enteral Nutrition Market Breakdown by Hypercaloric
        • 8.1.2.7.6 Czech Republic: Europe Enteral Nutrition Market Breakdown by Standard By Type
        • 8.1.2.7.7 Czech Republic: Europe Enteral Nutrition Market Breakdown by Standard By End User
      • 8.1.2.8 Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.2.8.1 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Product Type
        • 8.1.2.8.2 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
        • 8.1.2.8.3 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Standard By Calories
        • 8.1.2.8.4 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Isocaloric
        • 8.1.2.8.5 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Hypercaloric
        • 8.1.2.8.6 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Standard By Type
        • 8.1.2.8.7 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Standard By End User

9. Industry Landscape

  • 9.1 Overview
  • 9.2 Growth Strategies in Europe Enteral Nutrition Market
  • 9.3 Organic Growth Strategies
    • 9.3.1 Overview
  • 9.4 Inorganic Growth Strategies
    • 9.4.1 Overview

10. Company Profiles

  • 10.1 Nestle SA
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Danone SA
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Abbott Laboratories
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Royal FrieslandCampina NV
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 Fresenius SE & Co KGaA
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 B Braun SE
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 Reckitt Benckiser Group Plc
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 Kate Farms Inc
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Products and Services
    • 10.8.4 Financial Overview
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments
  • 10.9 Dr Schar AG
    • 10.9.1 Key Facts
    • 10.9.2 Business Description
    • 10.9.3 Products and Services
    • 10.9.4 Financial Overview
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Developments
  • 10.10 Fonterra Co-Operative Group Ltd
    • 10.10.1 Key Facts
    • 10.10.2 Business Description
    • 10.10.3 Products and Services
    • 10.10.4 Financial Overview
    • 10.10.5 SWOT Analysis
    • 10.10.6 Key Developments
  • 10.11 Arla Foods amba
    • 10.11.1 Key Facts
    • 10.11.2 Business Description
    • 10.11.3 Products and Services
    • 10.11.4 Financial Overview
    • 10.11.5 SWOT Analysis
    • 10.11.6 Key Developments
  • 10.12 Perrigo Co Plc
    • 10.12.1 Key Facts
    • 10.12.2 Business Description
    • 10.12.3 Products and Services
    • 10.12.4 Financial Overview
    • 10.12.5 SWOT Analysis
    • 10.12.6 Key Developments
  • 10.13 Charing Cross Scientific AS
    • 10.13.1 Key Facts
    • 10.13.2 Business Description
    • 10.13.3 Products and Services
    • 10.13.4 Financial Overview
    • 10.13.5 SWOT Analysis
    • 10.13.6 Key Developments
  • 10.14 Bexen Medical
    • 10.14.1 Key Facts
    • 10.14.2 Business Description
    • 10.14.3 Products and Services
    • 10.14.4 Financial Overview
    • 10.14.5 SWOT Analysis
    • 10.14.6 Key Developments

11. Appendix

  • 11.1 About The Insight Partners
  • 11.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Enteral Nutrition Market Segmentation
  • Table 2. Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 4. Sipping: Europe Enteral Nutrition Market, By Type (US$ Mn)
  • Table 5. Sipping: Europe Enteral Nutrition Market, By Standadr by Calories (US$ Mn)
  • Table 6. Sipping: Europe Enteral Nutrition Market, By Isocaloric (US$ Mn)
  • Table 7. Sipping: Europe Enteral Nutrition Market, By Hypercaloric (US$ Mn)
  • Table 8. Sipping: Europe Enteral Nutrition Market, By Standard by Type (US$ Mn)
  • Table 9. Sipping: Europe Enteral Nutrition Market, By Standard End User (US$ Mn)
  • Table 10. Sipping: Top 5 Europe Enteral Nutrition Markets (US$ Mn)
  • Table 11. Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Country
  • Table 12. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 13. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
  • Table 14. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
  • Table 15. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
  • Table 16. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
  • Table 17. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
  • Table 18. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
  • Table 19. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 20. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
  • Table 21. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
  • Table 22. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
  • Table 23. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
  • Table 24. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
  • Table 25. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
  • Table 26. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 27. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
  • Table 28. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
  • Table 29. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
  • Table 30. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
  • Table 31. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
  • Table 32. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
  • Table 33. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 34. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
  • Table 35. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
  • Table 36. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
  • Table 37. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
  • Table 38. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
  • Table 39. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
  • Table 40. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 41. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
  • Table 42. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
  • Table 43. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
  • Table 44. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
  • Table 45. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
  • Table 46. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
  • Table 47. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 48. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
  • Table 49. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
  • Table 50. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
  • Table 51. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
  • Table 52. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
  • Table 53. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
  • Table 54. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 55. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
  • Table 56. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
  • Table 57. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
  • Table 58. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
  • Table 59. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
  • Table 60. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
  • Table 61. Recent Organic Growth Strategies in Europe Enteral Nutrition Market
  • Table 62. Recent Inorganic Growth Strategies in the Europe Enteral Nutrition Market
  • Table 63. Glossary of Terms, Europe Enteral Nutrition Market

List Of Figures

  • Figure 1. Europe Enteral Nutrition Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Enteral Nutrition Market Revenue (US$ Million), 2021-2031
  • Figure 5. Europe Enteral Nutrition Market Share (%) - by Product Type, 2023 and 2031
  • Figure 6. Nasogastric: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Standard: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Disease Specific: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Nasoenteral: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Sipping: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Others: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Europe Enteral Nutrition Market Breakdown by Key Countries, 2023 and 2031 (%)
  • Figure 13. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Growth Strategies in Europe Enteral Nutrition Market